It has been revealed that high the expression of TUBA1C predicts a poor prognosis of hepatocellular carcinoma (Wang et al., 2017), lung adenocarcinoma (Bian et al., 2021), breast cancer (Wang et al., 2019), and osteosarcomas (Li et al., 2010). Here, TUBA1C is linked to osteosarcoma.